May 6, 2022
In a significant step forward in the study of alternative treatments for major depressive disorder, Cybin (NEO: CYBN) (NYSE American: CYBN) is moving forward in its phase 1/2a clinical trial of its proprietary deuterated psilocybin, CYB003 (https://ibn.fm/VTjoI). Based on previous research, CYB003 has the potential to effectively treat MDD with significant advantages over classic psilocybin.
Cybin announced that it has selected Clinilabs Drug Development Corporation to support the clinical trial. Clinilabs is a global, full-service contract research organization with an impressive reputation for its…
NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
President Trump’s controversial diesel deal with Russia may not actually bring down prices ahead of the midterms. Trump announced last week that Russia would “immediately” supply 300,000 tons of diesel to the U.S. and global marketplace, with another 500,000 tons coming in November, drawing howls from Democrats and some Republicans over lifting sanctions on Moscow...
Officers are investigating a serious incident
The couple are supporting a number of charities, including a community food project and a recording studio where Meghan will take part in an acting workshop.
The body of 49-year-old Douglas Craigie was recovered following a report of the missing boat off the Isle of Lewis - two crewmates, Murdo Morrison (pictured) and Tam Murray are missing.
William Chapman, 24, was mauled to death by 30st tiger Altai after climbing two fences and entering the enclosure on October 10, 2026, Doncaster Coroner's Court heard.
A man has died after a car crashed into a high street shop, sparking a large emergency response.
Simon Richardson denies murder and is on trial at Minshull Street Crown Court following the death of Michael Mullins
The Education Secretary is set to announce today that the ability to speak confidently will be 'hardwired' into a revised national curriculum.
Key Takeaways: Fugitive convicted in Justice Ran Bahadur Bam murder arrested in Sarlahi Police recovered two pistols ammunition and nearly Rs 518,000 in cash Thapa escaped from...
Catch up on local, national and international stories with the week’s multiple-choice challenge.
Catch up on local, national and international stories with the week’s multiple-choice challenge.